5-Isobutyl-2,3-dimethylpyrazine
| Common Name: |
5-Isobutyl-2,3-dimethylpyrazine |
| IUPAC Name: |
2,3-dimethyl-5-(2-methylpropyl)pyrazine |
| Molecular Formula: |
C6H8N2S |
| SMILES: |
CC1=NC=C(N=C1C)CC(C)C |
| Inchi: |
1S/C10H16N2/c1-7(2)5-10-6-11-8(3)9(4)12-10/h6-7H,5H2,1-4H3 |
| Inchi Key: |
HPAYBTQBMQPWCN-UHFFFAOYSA-N |
| Cas No: |
54410-83-2 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
3 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
140.21 |
| Mass (g/mol) |
164.131 |
| Molar Refractivity |
38.72 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
1 |
| Rings |
1 |
| TPSA |
51.08 |
| Hetero Atoms |
2 |
| Heavy Atoms |
9 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
225.00 to 226.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.13 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.33 |
| LogP |
2.292 |
| iLOGP |
1.58 |
| XLOGP3 |
0.96 |
| WLOGP |
1.51 |
| MLOGP |
0.13 |
| ESOL Log S |
-1.74 |
| ESOL Solubility (mg/ml) |
2.54 |
| ESOL Solubility (mol/l) |
0.018 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-1.62 |
| Ali Solubility (mg/ml) |
3.36 |
| Ali Solubility (mol/l) |
0.02 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-2.51 |
| Silicos-IT Solubility (mg/ml) |
0.43 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.47 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.597 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
0.128 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
